To determine whether utilization of serum miRNA test could improve treatment appropriateness and cost-effectiveness for stage I NSGCT patients.
A decision tree model was built to investigate treatment course, clinical and cost outcomes for patients with Stage IA (T1N0M0S0) and IB (T2-4N0M0S0) NSGCT.